How have INMB and TELA total returns compared?

Over the past 5 years, INMB delivered -36.88% and TELA delivered -38.71% annualized total return. Past performance doesn't predict future results.

INmune Bio, Inc. (INMB) vs TELA Bio, Inc. (TELA)

A side-by-side comparison of INmune Bio, Inc. and TELA Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

INMB

INmune Bio, Inc.

$50M

$1.87HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT

TELA

TELA Bio, Inc.

$49M

$1.10HealthcareDelayed quote: Oct 6, 2026, 2:20 PM EDT

Total return — INMB vs TELA

growth of $100 · dividends reinvested · last 7y

INMB -57.1% (-11.4%/yr)TELA -91.5% (-29.6%/yr)INMB compounded faster over this window

Log scale — wide-divergence pair

INMB TELA

INMB vs TELA: by the numbers

•INMB is the larger company ($50M vs $49M market cap).
•Both run net losses; TELA's is the smaller (-51.53% vs -91866.00% net margin).

Metrics side by side

Valuation

Metric	INMB	TELA
P/S ratio	N/A	0.62
P/B ratio	2.44	N/A

Profitability

Metric	INMB	TELA
Gross margin	100.00%	67.81%
Operating margin	-61738.00%	-42.56%
Net margin	-91866.00%	-51.53%
ROE	-90.44%	N/A
ROIC	-96.37%	-80.88%

Growth (annualized)

Metric	INMB	TELA
Revenue CAGR (5Y)	N/A	26.77%
Total return CAGR (5Y)	-36.88%	-38.71%

Frequently asked

How have INMB and TELA total returns compared?: Over the past 5 years, INMB delivered -36.88% and TELA delivered -38.71% annualized total return. Past performance doesn't predict future results.

Go deeper

Full INMB analysis Full TELA analysis Interactive comparison tool

Dig into the metrics

INmune Bio ROE TELA Bio ROE INmune Bio operating margin TELA Bio operating margin INmune Bio revenue growth TELA Bio revenue growth INmune Bio free cash flow TELA Bio free cash flow

INmune Bio & TELA Bio appear in these rankings

Fastest Revenue Growth Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.